Moderate-intensity aerobic and resistance exercise to reduce pain sensitization in breast cancer survivors
Official title: Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study
Run by Universidad Rey Juan Carlos · NCT07128030 · Data updated 2026-11-12
This program will try a supervised moderate-intensity aerobic plus resistance exercise regimen to see if it reduces pain sensitization and persistent upper-limb pain in breast cancer survivors.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Women only |
| Enrollment | 10 (estimated) |
| Sponsor | Universidad Rey Juan Carlos Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Madrid) |
| Status | Recruiting |
| Started | August 23, 2025 |
| Main results expected | February 23, 2026 |
| Study ends | February 23, 2026 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT07128030 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women with stage I–III breast cancer who finished active treatment at least six months ago, have persistent upper-limb pain or altered sensation related to treatment, can perform moderate-intensity exercise, and can attend sessions in Madrid (Spanish speakers).
✕Probably not a fit
People unlikely to benefit include those with bilateral breast cancer, locoregional recurrence, other active malignancies, pre-existing non–treatment-related pain, neurological or cognitive disorders, contraindications to moderate exercise, or who cannot attend sessions or speak Spanish.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a supervised, combined moderate-intensity aerobic and resistance training program aimed at reducing pain sensitization in women who completed treatment for stage I–III breast cancer at least six months earlier and who report persistent upper-quadrant pain. The primary goals are to test feasibility, safety, and acceptability of the exercise intervention. Secondary measures include changes in pain intensity, somatosensory sensitivity, and temporal summation using quantitative sensory testing, while tertiary outcomes track quality of life and functional capacity. The intervention is delivered at Universidad Rey Juan Carlos with clinical collaboration from Hospital General Universitario Gregorio Marañón in Madrid.
Why it matters
Potential benefit: If successful, the program could lower pain sensitization and chronic pain intensity, improving function and quality of life for breast cancer survivors.
How similar studies have gone: Previous exercise programs have shown improvements in pain, function, and quality of life for breast cancer survivors, but targeted interventions specifically focused on reducing pain sensitization and temporal summation are less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult women diagnosed with stage I-III breast cancer * Completion of active treatment (surgery, chemotherapy, and/or radiotherapy) at least 6 months prior to enrollment * Presence of persistent pain or altered sensation in the upper quadrant of the affected limb related to oncologic treatment Exclusion Criteria: * Bilateral breast cancer * Locoregional recurrence * Other malignancies * Pre-existing pain not related to cancer treatment * Neurological or cognitive disorders * Non-Spanish speakers * Contraindications to moderate-intensity physical activity
Where it's running
-
Universidad Rey Juan Carlos
Madrid, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced Music and Natural Visuals for Emotional Health
This trial tests whether using soundBrilliance software with music and natural visuals helps improve emotional health for people 13 and older.
-
Pain and moderate exercise in midlife former athletes, masters athletes, and nonathletes
This trial tests if moderate-intensity strength versus aerobic exercise changes pain before and after workouts in adults aged 35–65 who are former competitive athletes, current master's athletes, or nonathletes.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Outdoor resistance training for older adults
This trial tests a 6-week outdoor strength program using benches and a smartphone app to see if it’s safe, usable, and appealing for community-dwelling adults aged 65 and older.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.